$NRIX

$25.55 +$0.21 (0.83%) Close

$NRIX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$NRIX Management Team

Ms. Elizabeth Wolffe

Investor Relations

Age -

Compensation -

Sex Female

Dr. Arthur Sands

President

Chief Executive Officer

Director

Age 63

Compensation $5.813M USD

Sex Male

Dr. Gwenn Hansen

Chief Scientific Officer

Age 54

Compensation $2.034M USD

Sex Female

Dr. Christine Ring

Chief Legal Officer

Chief Compliance Officer

Secretary

Age 60

Compensation $2.016M USD

Sex Female

Ms. Julia Gregory

Independent Chairman of the Board

Age 72

Compensation $371.6K USD

Sex Female

Mr. Hans van Houte

Chief Financial Officer

Age 59

Compensation $2.016M USD

Sex Male

Mr. John Northcott

Chief Commercial Officer

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Elizabeth Wolffe Investor Relations	-	-	Female
Dr. Arthur Sands President Chief Executive Officer Director	63	$5.813M USD	Male
Dr. Gwenn Hansen Chief Scientific Officer	54	$2.034M USD	Female
Dr. Christine Ring Chief Legal Officer Chief Compliance Officer Secretary	60	$2.016M USD	Female
Ms. Julia Gregory Independent Chairman of the Board	72	$371.6K USD	Female
Mr. Hans van Houte Chief Financial Officer	59	$2.016M USD	Male
Mr. John Northcott Chief Commercial Officer	-	-	Male

Board of Directors

From the proxy statement filed Mar 27, 2026

Directors

serving now

Independent

8 of 8

stated in the proxy; 1 not stated

Average tenure

5.2 years

from year joined

CEO also chairs the board

Julia P. Gregory

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Arthur T. Sands CEO	64	2014 12 years	Not stated	None stated	None stated	Paid as CEO
Roger Dansey	69	2025 1 year	Independent	None stated	Bicycle Therapeutics plc	$421,684
Paul M. Silva	60	2021 5 years	Independent	Audit Committee · Chair Compensation Committee	Rapport Therapeutics, Inc.	$230,322
Julia P. Gregory Board chair	73	2019 7 years	Independent	Audit Committee Nominating and Corporate Governance Committee	Biohaven Ltd.	$258,968
Roy D. Baynes	71	2025 1 year	Independent	Clinical and Commercialization Committee · Chair	Aardvark Therapeutics, Inc., Natera, Inc., Travere Therapeutics, Inc., Adcendo ApS, CatalYm GmbH	Not stated
Anil Kapur	56	2024 2 years	Independent	None stated	Verastem, Inc.	$217,926
David L. Lacey	73	2016 10 years	Independent	Compensation Committee · Chair	Arcus Biosciences, Inc., Inbiomotion SL	$226,571
Judith A. Reinsdorf	62	2021 5 years	Independent	Audit Committee Nominating and Corporate Governance Committee · Chair	Enpro Inc., Toll Brothers, Inc.	$229,072
Edward C. Saltzman	71	2022 4 years	Independent	None stated	None stated	$220,218

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Mar 27, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$NRIX Management Team

Ms. Elizabeth Wolffe

Dr. Arthur Sands

Dr. Gwenn Hansen

Dr. Christine Ring

Ms. Julia Gregory

Mr. Hans van Houte

Mr. John Northcott

Board of Directors

Related-party transactions

No related-party transactions disclosed